Of note, Li and colleagues have recently reported that high PTP4A2 expression downregulated the PTEN level by dephosphorylation, suggesting that PTP4A2 supports oncogenic propensity of PTEN deletion in cancer (8). The gene discussed is PTP4A2; the disease is cancer.